-
1
-
-
0035033922
-
Vasoactive intestinal peptide prevents experimental arthritis by down-regulating both autoimmune and inflammatory components of the disease
-
Delgado M, Abad C, Martinez C, Leceta J, Gomariz RP Vasoactive intestinal peptide prevents experimental arthritis by down-regulating both autoimmune and inflammatory components of the disease. Nature Medicine 2001, 7:563-568.
-
(2001)
Nature Medicine
, vol.7
, pp. 563-568
-
-
Delgado, M.1
Abad, C.2
Martinez, C.3
Leceta, J.4
Gomariz, R.P.5
-
2
-
-
0027287290
-
Transmitter role of vasoactive intestinal peptide
-
Fahrenkrug J Transmitter role of vasoactive intestinal peptide. Pharmacology and Toxicology 1989, 72:354-363.
-
(1989)
Pharmacology and Toxicology
, vol.72
, pp. 354-363
-
-
Fahrenkrug, J.1
-
3
-
-
0035923540
-
Enhanced delayed-type hypersensitivity and diminished immediate-type hypersensitivity in mice lacking the inducible VPAC2 receptor for vasoactive intestinal peptide
-
Goetzl EJ, Voice JK, Shen S, Dorsam G, Kong Y, West KM, Morrison CF, Harmar AJ Enhanced delayed-type hypersensitivity and diminished immediate-type hypersensitivity in mice lacking the inducible VPAC2 receptor for vasoactive intestinal peptide. Proceedings of the National Academy of Sciences USA 2001, 98:13854-13859.
-
(2001)
Proceedings of the National Academy of Sciences USA
, vol.98
, pp. 13854-13859
-
-
Goetzl, E.J.1
Voice, J.K.2
Shen, S.3
Dorsam, G.4
Kong, Y.5
West, K.M.6
Morrison, C.F.7
Harmar, A.J.8
-
5
-
-
0032564460
-
Vasoactive intestinal peptide inhibits human small-cell lung cancer proliferation in vitro and in vivo
-
Maruno K, Absood A, Said SI Vasoactive intestinal peptide inhibits human small-cell lung cancer proliferation in vitro and in vivo. Proceedings of the National Academy of Sciences USA 1998, 95:14373-14378.
-
(1998)
Proceedings of the National Academy of Sciences USA
, vol.95
, pp. 14373-14378
-
-
Maruno, K.1
Absood, A.2
Said, S.I.3
-
6
-
-
0038369941
-
Vasoactive intestinal peptide as a new drug for treatment of primary pulmonary hypertension
-
Petkov V, Mosgoeller W, Ziesche R, Raderer M, Stiebellehner L, Vonbank K, Funk GC, Hamilton G, Novotny C, Burian B, Block LH Vasoactive intestinal peptide as a new drug for treatment of primary pulmonary hypertension. Journal of Clinical Investigation 2003, 111:1339-1346.
-
(2003)
Journal of Clinical Investigation
, vol.111
, pp. 1339-1346
-
-
Petkov, V.1
Mosgoeller, W.2
Ziesche, R.3
Raderer, M.4
Stiebellehner, L.5
Vonbank, K.6
Funk, G.C.7
Hamilton, G.8
Novotny, C.9
Burian, B.10
Block, L.H.11
-
7
-
-
0003098902
-
Anti-inflammatory actions of VIP in the lungs and airways
-
Marcel Dekker, Inc., New York, S.I. Said, C. Lenfant (Eds.) Pro-Inflammatory and Anti-Inflammatory Peptides
-
Said SI Anti-inflammatory actions of VIP in the lungs and airways. Lung Biology in Health and Disease 1998, Vol. 112:345-361. Marcel Dekker, Inc., New York. S.I. Said, C. Lenfant (Eds.).
-
(1998)
Lung Biology in Health and Disease
, vol.112
, pp. 345-361
-
-
Said, S.I.1
-
8
-
-
0030585049
-
Molecules that protect: the defense of neurons and other cells (editorial)
-
Said SI Molecules that protect: the defense of neurons and other cells (editorial). Journal of Clinical Investigation 1995, 96:2163-2164.
-
(1995)
Journal of Clinical Investigation
, vol.96
, pp. 2163-2164
-
-
Said, S.I.1
-
9
-
-
0024564484
-
Vasoactive intestinal polypeptide and asthma (editorial)
-
Said SI Vasoactive intestinal polypeptide and asthma (editorial). New England Journal of Medicine 1989, 320:1271-1273.
-
(1989)
New England Journal of Medicine
, vol.320
, pp. 1271-1273
-
-
Said, S.I.1
|